ClinConnect ClinConnect Logo
Search / Trial NCT04657835

Assessment of Atrial Cardiomyopathy Using MRI as a Predictor of Cardiac Post-Operative Atrial Fibrillation After Cardiac Surgery.

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Dec 1, 2020

Trial Information

Current as of May 01, 2025

Not yet recruiting

Keywords

Post Operative Atrial Fibrillation Magnetic Resonance Imaging Coronary Artery Bypass Grafting (Cabg)

ClinConnect Summary

This clinical trial is looking at how well a special type of MRI can help predict a common heart problem called postoperative atrial fibrillation (POAF) after heart surgery, specifically coronary artery bypass grafting (CABG). POAF occurs when the heart's upper chambers don't beat in a regular rhythm after surgery, and it can lead to complications. The researchers believe that using advanced MRI techniques can provide more detailed information about heart changes, known as atrial cardiomyopathy, than current methods like echocardiograms (ultrasound of the heart) or electrocardiograms (tests that check the heart's rhythm).

To be eligible for the study, participants must be 18 years or older and scheduled for CABG surgery. They should also be part of a social security program and agree to join the study. However, those with certain health conditions, previous atrial fibrillation, or who are pregnant or breastfeeding cannot participate. If you join the study, you can expect to undergo an MRI that helps researchers understand the heart's condition better, which could lead to improved care and treatment for patients after heart surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Indication for surgical myocardial revascularization by coronary artery bypass
  • Patient affiliated or entitled to a social security scheme
  • Informed consent for participation in the study
  • Exclusion Criteria:
  • Contraindication to cardiac MRI (Severe Kidney disease, Allergy to gadoliniumn, ...)
  • History of Atriale Fibrillation (AF)
  • Indication of cardiac valve surgery concomitantly with Coronary Artery Bypass Grafting (CABG).
  • pregnant or breast-feeding women

About Centre Hospitalier Universitaire De Saint Etienne

The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.

Locations

Saint étienne, , France

Patients applied

0 patients applied

Trial Officials

Jean-Baptiste GUICHARD, MD

Principal Investigator

CHU SAINT-ETIENNE

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials